These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Lee MR, Wehring HJ, McMahon RP, Linthicum J, Cascella N, Liu F, Bellack A, Buchanan RW, Strauss GP, Contoreggi C, Kelly DL. Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472 [Abstract] [Full Text] [Related]
6. Contributions of olfactory and neuropsychological assessment to the diagnosis of first-episode schizophrenia. Kamath V, Crawford J, DuBois S, Nucifora FC, Nestadt G, Sawa A, Schretlen D. Neuropsychology; 2019 Feb; 33(2):203-211. PubMed ID: 30475048 [Abstract] [Full Text] [Related]
8. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Good KP, Whitehorn D, Rui Q, Milliken H, Kopala LC. Am J Psychiatry; 2006 May; 163(5):932-3. PubMed ID: 16648339 [Abstract] [Full Text] [Related]
13. Smell identification in individuals at clinical high risk for schizophrenia. Gill KE, Evans E, Kayser J, Ben-David S, Messinger J, Bruder G, Malaspina D, Corcoran CM. Psychiatry Res; 2014 Dec 15; 220(1-2):201-4. PubMed ID: 25066961 [Abstract] [Full Text] [Related]
17. Overrated hedonic judgment of odors in patients with schizophrenia. Urban-Kowalczyk M, Śmigielski J, Kotlicka-Antczak M. CNS Neurosci Ther; 2018 Dec 15; 24(12):1156-1162. PubMed ID: 29638031 [Abstract] [Full Text] [Related]